(September 16, 2024, 1:38 PM EDT) -- DENVER — Eli Lilly and Co. and HydraMed IV LLC have reached a settlement to end a trademark infringement dispute, with the mobile IV treatment company HydraMed agreeing to a permanent injunction barring the company from advertising or selling compounded medications that lead consumers to believe that they are generic versions of Lilly’s weight loss medications....